The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
A guide to immunotherapy for COVID-19
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
WHO Solidarity Trial Consortium (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2023184 · Cited by 2,745
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
Feldstein, L. R., Rose, E. B., Horwitz, S. M., Collins, J. P., Newhams, M. M., Son, M. B. F., Newburger, J. W., Kleinman, L. C., Heidemann, S. M., Martin, A. A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021680 · Cited by 2,643
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne, J. A. C., Murthy, S., Diaz, J. V., Slutsky, A. S., Villar, J., Angus, D. C., Annane, D., Azevedo, L. C. P., Berwanger, O., et al. (2020) · JAMA · doi:10.1001/jama.2020.17023 · Cited by 2,257
Self-citationClinical Characteristics of Covid-19 in New York City
Goyal, P., Choi, J. J., Pinheiro, L. C., Schenck, E. J., Chen, R., Jabri, A., Satlin, M. J., Campion, T. R., Nahid, M., Ringel, J. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2010419 · Cited by 2,234
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Giamarellos-Bourboulis, E. J., Netea, M. G., Rovina, N., Akinosoglou, K., Antoniadou, A., Antonakos, N., Damoraki, G., Gkavogianni, T., Adami, M.-E., Katsaounou, P., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.009 · Cited by 2,045
Self-citationWhittaker, E., Bamford, A., Kenny, J., Kaforou, M., Jones, C. E., Shah, P., Ramnarayan, P., Fraisse, A., Miller, O., Davies, P., et al. (2020) · JAMA · doi:10.1001/jama.2020.10369 · Cited by 1,994
Abani, O., Abbas, A., Abbas, F., Abbas, M., Abbasi, S., Abbass, H., Abbott, A., Abdallah, N., Abdelaziz, A., Abdelfattah, M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00676-0 · Cited by 1,983
Interleukin-6 receptor antagonists in critically ill patients with Covid-19.
The REMAP-CAP Investigators (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100433 · Cited by 1,962
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
Kalil, A. C., Patterson, T. F., Mehta, A. K., Tomashek, K. M., Wolfe, C. R., Ghazaryan, V., Marconi, V. C., Ruiz-Palacios, G. M., Hsieh, L., Kline, S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2031994 · Cited by 1,835
Mathew, D., Giles, J. R., Baxter, A. E., Oldridge, D. A., Greenplate, A. R., Wu, J. E., Alanio, C., Kuri-Cervantes, L., Pampena, M. B., D’Andrea, K., et al. (2020) · Science · doi:10.1126/science.abc8511 · Cited by 1,509
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Hou, Y. J., Okuda, K., Edwards, C. E., Martinez, D. R., Asakura, T., Dinnon, K. H., Kato, T., Lee, R. E., Yount, B. L., Mascenik, T. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.042 · Cited by 1,488
Hung, I. F.-N., Lung, K.-C., Tso, E. Y.-K., Liu, R., Chung, T. W.-H., Chu, M.-Y., Ng, Y.-Y., Lo, J., Chan, J., Tam, A. R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31042-4 · Cited by 1,455
Du, R.-H., Liang, L.-R., Yang, C.-Q., Wang, W., Cao, T.-Z., Li, M., Guo, G.-Y., Du, J., Zheng, C.-L., Zhu, Q., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00524-2020 · Cited by 1,452
Tomazini, B. M., Maia, I. S., Cavalcanti, A. B., Berwanger, O., Rosa, R. G., Veiga, V. C., Avezum, A., Lopes, R. D., Bueno, F. R., Silva, M. V. A. O., et al. (2020) · JAMA · doi:10.1001/jama.2020.17021 · Cited by 1,241
Monocyte deactivation in septic patients: Restoration by IFN-γ treatment
Döcke, W.-D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H.-D., & Kox, W. (1997) · Nature Medicine · doi:10.1038/nm0697-678 · Cited by 1,190
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Richeldi, L., Costabel, U., Selman, M., Kim, D. S., Hansell, D. M., Nicholson, A. G., Brown, K. K., Flaherty, K. R., Noble, P. W., Raghu, G., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103690 · Cited by 1,157
Toubiana, J., Poirault, C., Corsia, A., Bajolle, F., Fourgeaud, J., Angoulvant, F., Debray, A., Basmaci, R., Salvador, E., Biscardi, S., et al. (2020) · BMJ · doi:10.1136/bmj.m2094 · Cited by 1,144
RECOVERY Collaborative Group (2021) · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · doi:10.17863/cam.70428 · Cited by 1,067
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
The ATTACC, A.-4. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2105911 · Cited by 1,046
A living WHO guideline on drugs for covid-19 (2020-2023)
Agarwal, A., Hunt, B. J., Stegemann, M., Rochwerg, B., Lamontagne, F., Siemieniuk, R. A., Agoritsas, T., Askie, L., Lytvyn, L., Leo, Y.-S., et al. (2020) · BMJ · doi:10.1136/bmj.m3379 · Cited by 1,041
Self-citationChen, X., Zhao, B., Qu, Y., Chen, Y., Xiong, J., Feng, Y., Men, D., Huang, Q., Liu, Y., Yang, B., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa449 · Cited by 1,020
Kinase inhibitors: the road ahead
Ferguson, F. M., & Gray, N. S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.21 · Cited by 1,009
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Bonaventura, A., Vecchié, A., Dagna, L., Martinod, K., Dixon, D. L., Van Tassell, B. W., Dentali, F., Montecucco, F., Massberg, S., Levi, M., et al. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00536-9 · Cited by 987
A dynamic COVID-19 immune signature includes associations with poor prognosis
Laing, A. G., Lorenc, A., del Molino del Barrio, I., Das, A., Fish, M., Monin, L., Muñoz-Ruiz, M., McKenzie, D. R., Hayday, T. S., Francos-Quijorna, I., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1038-6 · Cited by 946
Self-citationTherapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
The REMAP-CAP, A.-4. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2103417 · Cited by 941
Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection
Diao, B., Wang, C., Wang, R., Feng, Z., Zhang, J., Yang, H., Tan, Y., Wang, H., Wang, C., Liu, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22781-1 · Cited by 900
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
Libster, R., Pérez Marc, G., Wappner, D., Coviello, S., Bianchi, A., Braem, V., Esteban, I., Caballero, M. T., Wood, C., Berrueta, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2033700 · Cited by 873
Gottlieb, R. L., Nirula, A., Chen, P., Boscia, J., Heller, B., Morris, J., Huhn, G., Cardona, J., Mocherla, B., Stosor, V., et al. (2021) · JAMA · doi:10.1001/jama.2021.0202 · Cited by 872
Mandal, S., Barnett, J., Brill, S. E., Brown, J. S., Denneny, E. K., Hare, S. S., Heightman, M., Hillman, T. E., Jacob, J., Jarvis, H. C., et al. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-215818 · Cited by 864
The Writing Committee for the REMAP-CAP Investigators, Angus, D. C., Derde, L., Al-Beidh, F., Annane, D., Arabi, Y., Beane, A., van Bentum-Puijk, W., Berry, L., Bhimani, Z., et al. (2020) · JAMA · doi:10.1001/jama.2020.17022 · Cited by 855
Self-citationLiu, L., Wei, Q., Lin, Q., Fang, J., Wang, H., Kwok, H., Tang, H., Nishiura, K., Peng, J., Tan, Z., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.123158 · Cited by 830
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Bloch, E. M., Shoham, S., Casadevall, A., Sachais, B. S., Shaz, B., Winters, J. L., van Buskirk, C., Grossman, B. J., Joyner, M., Henderson, J. P., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138745 · Cited by 799
Aiello, A., Farzaneh, F., Candore, G., Caruso, C., Davinelli, S., Gambino, C. M., Ligotti, M. E., Zareian, N., & Accardi, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02247 · Cited by 693
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Domingo, P., Mur, I., Mateo, G. M., Gutierrez, M. D. M., Pomar, V., de Benito, N., Corbacho, N., Herrera, S., Millan, L., et al. (2021) · JAMA · doi:10.1001/jama.2021.11330 · Cited by 678
Self-citationLymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis
Huang, I., & Pranata, R. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-00453-4 · Cited by 662
INSPIRATION Investigators, Mazloomzadeh, S., Khaleghparast, S., Ghadrdoost, B., Mousavizadeh, M., Baay, M. R., Noohi, F., Sharifnia, H., Ahmadi, A., Tavan, S., et al. (2021) · JAMA · doi:10.1001/jama.2021.4152 · Cited by 625
The role of IgG Fc receptors in antibody-dependent enhancement
Bournazos, S., Gupta, A., & Ravetch, J. V. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00410-0 · Cited by 617
Cheung, E. W., Zachariah, P., Gorelik, M., Boneparth, A., Kernie, S. G., Orange, J. S., & Milner, J. D. (2020) · JAMA · doi:10.1001/jama.2020.10374 · Cited by 568
Pouletty, M., Borocco, C., Ouldali, N., Caseris, M., Basmaci, R., Lachaume, N., Bensaid, P., Pichard, S., Kouider, H., Morelle, G., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217960 · Cited by 542
Kyriazopoulou, E., Poulakou, G., Milionis, H., Metallidis, S., Adamis, G., Tsiakos, K., Fragkou, A., Rapti, A., Damoulari, C., Fantoni, M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01499-z · Cited by 536
Self-citationHenderson, L. A., Canna, S. W., Friedman, K. G., Gorelik, M., Lapidus, S. K., Bassiri, H., Behrens, E. M., Ferris, A., Kernan, K. F., Schulert, G. S., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41454 · Cited by 531
Morris, S. B., Schwartz, N. G., Patel, P., Abbo, L., Beauchamps, L., Balan, S., Lee, E. H., Paneth-Pollak, R., Geevarughese, A., Lash, M. K., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6940e1 · Cited by 523
Nakra, N., Blumberg, D., Herrera-Guerra, A., & Lakshminrusimha, S. (2020) · Children · doi:10.3390/children7070069 · Cited by 512
Schurink, B., Roos, E., Radonic, T., Barbe, E., Bouman, C. S. C., de Boer, H. H., de Bree, G. J., Bulle, E. B., Aronica, E. M., Florquin, S., et al. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30144-0 · Cited by 512
Self-citationAbani, O., Abbas, A., Abbas, F., Abbas, M., Abbasi, S., Abbass, H., Abbott, A., Abdallah, N., Abdelaziz, A., Abdelfattah, M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00897-7 · Cited by 492
Ritis, K., Doumas, M., Mastellos, D., Micheli, A., Giaglis, S., Magotti, P., Rafail, S., Kartalis, G., Sideras, P., & Lambris, J. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4794 · Cited by 489
Lopes, R. D., de Barros e Silva, P. G. M., Furtado, R. H. M., Macedo, A. V. S., Bronhara, B., Damiani, L. P., Barbosa, L. M., de Aveiro Morata, J., Ramacciotti, E., de Aquino Martins, P., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01203-4 · Cited by 481
Treatment of SARS with human interferons
Cinatl, J., Morgenstern, B., Bauer, G., Chandra, P., Rabenau, H., & Doerr, H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13973-6 · Cited by 467
Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
Iskander, K. N., Osuchowski, M. F., Stearns-Kurosawa, D. J., Kurosawa, S., Stepien, D., Valentine, C., & Remick, D. G. (2013) · Physiological Reviews · doi:10.1152/physrev.00037.2012 · Cited by 453
Monk, P. D., Marsden, R. J., Tear, V. J., Brookes, J., Batten, T. N., Mankowski, M., Gabbay, F. J., Davies, D. E., Holgate, S. T., Ho, L.-P., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30511-7 · Cited by 438
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
Guimarães, P. O., Quirk, D., Furtado, R. H., Maia, L. N., Saraiva, J. F., Antunes, M. O., Kalil Filho, R., Junior, V. M., Soeiro, A. M., Tognon, A. P., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2101643 · Cited by 435
Lee, P. Y., Day-Lewis, M., Henderson, L. A., Friedman, K. G., Lo, J., Roberts, J. E., Lo, M. S., Platt, C. D., Chou, J., Hoyt, K. J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci141113 · Cited by 396
Piechotta, V., Chai, K. L., Valk, S. J., Doree, C., Monsef, I., Wood, E. M., Lamikanra, A., Kimber, C., McQuilten, Z., So-Osman, C., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013600.pub2 · Cited by 367
Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes
Son, M. B. F., Murray, N., Friedman, K., Young, C. C., Newhams, M. M., Feldstein, L. R., Loftis, L. L., Tarquinio, K. M., Singh, A. R., Heidemann, S. M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2102605 · Cited by 366
Ramcharan, T., Nolan, O., Lai, C. Y., Prabhu, N., Krishnamurthy, R., Richter, A. G., Jyothish, D., Kanthimathinathan, H. K., Welch, S. B., Hackett, S., et al. (2020) · Pediatric Cardiology · doi:10.1007/s00246-020-02391-2 · Cited by 364
Ouldali, N., Toubiana, J., Antona, D., Javouhey, E., Madhi, F., Lorrot, M., Léger, P.-L., Galeotti, C., Claude, C., Wiedemann, A., et al. (2021) · JAMA · doi:10.1001/jama.2021.0694 · Cited by 354
Treatment of Multisystem Inflammatory Syndrome in Children
McArdle, A. J., Vito, O., Patel, H., Seaby, E. G., Shah, P., Wilson, C., Broderick, C., Nijman, R., Tremoulet, A. H., Munblit, D., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2102968 · Cited by 352
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome
van de Veerdonk, F. L., Netea, M. G., van Deuren, M., van der Meer, J. W., de Mast, Q., Brüggemann, R. J., & van der Hoeven, H. (2020) · eLife · doi:10.7554/elife.57555 · Cited by 284
Self-citationTharaux, P.-L., Pialoux, G., Pavot, A., Mariette, X., Hermine, O., Resche-Rigon, M., Porcher, R., Ravaud, P., Bureau, S., Dougados, M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30556-7 · Cited by 284
RECOVERY Collaborative Group, Horby, P., Mafham, M. M., Peto, L., Campbell, M. R., Pessoa-Amorim, G., Spata, E., Staplin, N., Emberson, J., Prudon, B., et al. (2021) · medRxiv · doi:10.1101/2021.06.15.21258542 · Cited by 206
Vlaar, A. P. J., de Bruin, S., Busch, M., Timmermans, S. A. M. E. G., van Zeggeren, I. E., Koning, R., ter Horst, L., Bulle, E. B., van Baarle, F. E. H. P., van de Poll, M. C. G., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30341-6 · Cited by 194
Self-citationRecent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19
Talasaz, A. H., Sadeghipour, P., Kakavand, H., Aghakouchakzadeh, M., Kordzadeh-Kermani, E., Van Tassell, B. W., Gheymati, A., Ariannejad, H., Hosseini, S. H., Jamalkhani, S., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.02.035 · Cited by 184
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19
O’Donnell, M. R., Grinsztejn, B., Cummings, M. J., Justman, J. E., Lamb, M. R., Eckhardt, C. M., Philip, N. M., Cheung, Y. K., Gupta, V., João, E., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci150646 · Cited by 179
Rovina, N., Akinosoglou, K., Eugen-Olsen, J., Hayek, S., Reiser, J., & Giamarellos-Bourboulis, E. J. (2020) · Critical Care · doi:10.1186/s13054-020-02897-4 · Cited by 173
Self-citationMultisystem inflammatory syndrome in children related to COVID‐19: A New York City experience
Riollano‐Cruz, M., Akkoyun, E., Briceno‐Brito, E., Kowalsky, S., Reed, J., Posada, R., Sordillo, E. M., Tosi, M., Trachtman, R., & Paniz‐Mondolfi, A. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26224 · Cited by 170
Deciphering the state of immune silence in fatal COVID-19 patients
Bost, P., Sanctis, F. D., Canè, S., Ugel, S., Donadello, K., Castellucci, M., David, E., Fiore, A., Anselmi, C., Barouni, R. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21702-6 · Cited by 167
Caricchio, R., Abbate, A., Gordeev, I., Meng, J., Hsue, P. Y., Neogi, T., Arduino, R., Fomina, D., Bogdanov, R., Stepanenko, T., et al. (2021) · JAMA · doi:10.1001/jama.2021.9508 · Cited by 164
Shankar‐Hari, M., Spencer, J., Sewell, W. A., Rowan, K., & Singer, M. (2011) · Critical Care · doi:10.1186/cc10597 · Cited by 141
Self-citationClinical features and prognostic factors in Covid-19: A prospective cohort study
de Bruin, S., Bos, L. D. J., van ROON, M. A., Boer, A. M. T., Schuurman, A. R., Koel-Simmelinck, M. J. A., Bogaard, H. J., Tuinman, P. R., van Agtmael, M. A., Hamann, J., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103378 · Cited by 139
Self-citationSoluble Urokinase Receptor (SuPAR) in COVID-19–Related AKI
Azam, T. U., Shadid, H. R., Blakely, P. K., O’Hayer, P., Berlin, H. P., Pan, M. M., Zhao, P., Zhao, L., Pennathur, S., Pop‐Busui, R., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020060829 · Cited by 128
Self-citationKambas, K., Markiewski, M. M., Pneumatikos, I. A., Rafail, S. S., Theodorou, V., Konstantonis, D., Kourtzelis, I., Doumas, M. N., Magotti, P., DeAngelis, R. A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7368 · Cited by 127
Kreutmair, S., Unger, S., Núñez, N. G., Ingelfinger, F., Alberti, C., Feo, D. D., Krishnarajah, S., Kauffmann, M., Friebel, E., Babaei, S., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.05.002 · Cited by 121
Aman, J., Duijvelaar, E., Botros, L., Kianzad, A., Schippers, J. R., Smeele, P. J., Azhang, S., Bartelink, I. H., Bayoumy, A. A., Bet, P. M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00237-x · Cited by 121
Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
Richeldi, L., Kolb, M. R. J., Jouneau, S., Wuyts, W. A., Schinzel, B., Stowasser, S., Quaresma, M., & Raghu, G. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-1030-4 · Cited by 105
Ruscitti, P., Berardicurti, O., Benedetto, P. D., Cipriani, P., Iagnocco, A., Shoenfeld, Y., & Giacomelli, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01130 · Cited by 104
Laterre, P., François, B., Collienne, C., Hantson, P. E., Jeannet, R., Remy, K. E., & Hotchkiss, R. S. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.16485 · Cited by 99
Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19
Janssen, N. A. F., Grondman, I., de Nooijer, A., Boahen, C. K., Koeken, V. A. C. M., Matzaraki, V., Kumar, V., He, X., Kox, M., Koenen, H. J. P. M., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab065 · Cited by 96
Self-citationA Longitudinal Study of Immune Cells in Severe COVID-19 Patients
Payen, D. M., Cravat, M., Maadadi, H., Didelot, C., Prosic, L., Dupuis, C., Losser, M.-R., & Bittencourt, M. D. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.580250 · Cited by 82
Seshan, S. V., Franzke, C.-W., Redecha, P. B., Monestier, M., Mackman, N., & Girardi, G. (2009) · Blood · doi:10.1182/blood-2009-01-199117 · Cited by 80
Use of convalescent plasma in COVID ‐19 patients with immunosuppression
Senefeld, J. W., Klassen, S. A., Ford, S. K., Senese, K. A., Wiggins, C. C., Bostrom, B., Thompson, M. A., Baker, S. E., Nicholson, W. T., Johnson, P. W., et al. (2021) · Transfusion · doi:10.1111/trf.16525 · Cited by 80
The REMAP-CAP Investigators, & Derde, L. P. G. (2021) · medRxiv · doi:10.1101/2021.06.18.21259133 · Cited by 74
Self-citationAlveolar compartmentalization of inflammatory and immune cell biomarkers in pneumonia-related ARDS
Bendib, I., Beldi‐Ferchiou, A., Schlemmer, F., Surénaud, M., Maître, B., Plonquet, A., Carteaux, G., Razazi, K., Godot, V., Hüe, S., et al. (2021) · Critical Care · doi:10.1186/s13054-020-03427-y · Cited by 73
Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19
van de Veerdonk, F. L., Kouijzer, I. J. E., de Nooijer, A. H., van der Hoeven, H. G., Maas, C., Netea, M. G., & Brüggemann, R. J. M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.17708 · Cited by 65
Self-citationObi, A. T., Barnes, G. D., Napolitano, L. M., Henke, P. K., & Wakefield, T. W. (2020) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2020.08.030 · Cited by 63
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)
Patel, J., Bass, D., Beishuizen, A., Ruiz, X. B., Boughanmi, H., Cahn, A. P., Colombo, H. R., Criner, G. J., Davy, K., de Miguel‐Díez, J., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01870-2021 · Cited by 61
van Laarhoven, A., Kurver, L., Overheul, G. J., Kooistra, E. J., Abdo, W. F., van Crevel, R., Duivenvoorden, R., Kox, M., ten Oever, J., Schouten, J. A., et al. (2021) · Med · doi:10.1016/j.medj.2021.09.003 · Cited by 51
Self-citationAdult multisystem inflammatory syndrome in a patient who recovered from COVID-19 postvaccination
Uwaydah, A. K., Hassan, N. M. M., Ghoush, M. S. A., & Shahin, K. M. M. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-242060 · Cited by 48
Nguyen, L. S., Hamou, Z. A., Gastli, N., Chapuis, N., & Pène, F. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06377-3 · Cited by 37
Lung compartmentalization of inflammatory biomarkers in COVID-19-related ARDS
Jouan, Y., Baranek, T., Si‐Tahar, M., Paget, C., & Guillon, A. (2021) · Critical Care · doi:10.1186/s13054-021-03513-9 · Cited by 37
Muñoz‐Rivas, N., Abad‐Motos, A., Mestre-Gómez, B., Hidalgo, F. S., Cortina, C., Lorente‐Ramos, R. M., Rubio, P. T., García, P. A., Franco‐Moreno, A., Mariscal, E. G., et al. (2021) · Thrombosis Research · doi:10.1016/j.thromres.2020.12.024 · Cited by 36
Mansour, E., Bueno, F. F., Júnior, J. C. D. L., Palma, A. C., Monfort‐Pires, M., Bombassaro, B., ARAUJO, E. P. D., Bernardes, A. F., Ulaf, R. G., Nunes, T. A., et al. (2021) · Trials · doi:10.1186/s13063-021-05027-9 · Cited by 32
Plasma Therapy to Prevent Severe Covid-19 in Older Adults. Reply.
Wappner, D., Bergel, E. F., & Polack, F. P. (2021) · PubMed · doi:10.1056/nejmc2104747 · Cited by 26
Jacobs, C. F., Eldering, E., & Kater, A. P. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003768 · Cited by 21
Menshawey, R., Menshawey, E., Alserr, A. H. K., & AbdelMassih, A. F. (2020) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000237 · Cited by 7
Cited by
Therapeutic strategies for COVID-19: progress and lessons learned
Li, G., Hilgenfeld, R., Whitley, R., & De Clercq, E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00672-y · Cited by 676
COVID-19-associated fungal infections
Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G. H., Ibrahim, A. S., & Carvalho, A. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01172-2 · Cited by 482
Nanoparticles: Taking a Unique Position in Medicine
Joseph, T., Kar Mahapatra, D., Esmaeili, A., Piszczyk, Ł., Hasanin, M., Kattali, M., Haponiuk, J., & Thomas, S. (2023) · Nanomaterials · doi:10.3390/nano13030574 · Cited by 480
Understanding COVID-19-associated coagulopathy
Conway, E. M., Mackman, N., Warren, R. Q., Wolberg, A. S., Mosnier, L. O., Campbell, R. A., Gralinski, L. E., Rondina, M. T., van de Veerdonk, F. L., Hoffmeister, K. M., et al. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00762-9 · Cited by 359
Self-citationHumoral Innate Immunity and Acute-Phase Proteins
Mantovani, A., & Garlanda, C. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2206346 · Cited by 310
Metadata
- Authors
- van de Veerdonk, F. L., Giamarellos-Bourboulis, E., Pickkers, P., Derde, L., Leavis, H., van Crevel, R., Engel, J. J., Wiersinga, W. J., Vlaar, A. P. J., Shankar-Hari, M., van der Poll, T., Bonten, M., Angus, D. C., van der Meer, J. W. M., & Netea, M. G.
- Venue
- Nature Medicine
- Published
- 2022-01
- Volume
- 28
- Issue
- 1
- Pages
- 39-50
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W4206989777
- Cited by
- 320
- References
- 101
- FWCI
- 36.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.